Viewing StudyNCT03101748



Ignite Creation Date: 2024-05-06 @ 9:54 AM
Last Modification Date: 2024-10-26 @ 12:21 PM
Study NCT ID: NCT03101748
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-03
First Post: 2017-03-30

Brief Title: Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-01-29
Start Date Type: ACTUAL
Primary Completion Date: 2026-01-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-01-01
Completion Date Type: ESTIMATED
First Submit Date: 2017-03-30
First Submit QC Date: March 30 2017
Study First Post Date: 2017-04-05
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-05-30
Last Update Post Date: 2024-06-03
Last Update Post Date Type: ACTUAL